Position in OTLK
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$56,650
New position
Shares Held
275,000
first reported quarter
Ownership
0.228%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#7
of 54 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Warberg Asset Management LLC holds $207,206 across 6 Biotechnology names. OTLK ranks #2 (27.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CLDI |
Calidi Biotherapeutics, Inc.
|
250,000 | $59,750 | |
| 2 | OTLK |
Outlook Therapeutics, Inc.
This page
|
275,000 | $56,650 | |
| 3 | VANI |
Vivani Medical, Inc.
|
40,000 | $40,000 | |
| 4 | CLRB |
Cellectar Biosciences, Inc.
|
13,900 | $35,306 | |
| 5 | ERNA |
Ernexa Therapeutics Inc.
|
50,000 | $10,000 | |
| 6 | CRIS |
Curis Inc
|
10,000 | $5,500 |
All Filings in OTLK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $56,650 | 275,000 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||